fbpx Back to Top

Retinal Vein Occlusion

Get Help with Your Treatment

Apply Online or call 1-866-316-7263

 

Program Status

Open - We are accepting applications for new and renewal patients. If your application for assistance is approved you can begin receiving funding immediately.

 

Assistance Amount

$1,800 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

  1. The patient must be getting treatment for retinal vein occlusion.
  2. The patient must have Medicare health insurance that covers his or her qualifying medication or product.   
  3. The patient’s medication or product must be listed on PAN’s list of covered medications.
  4. The patient’s income must fall at or below 500% of the Federal Poverty Level.
  5. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
list icon
See the list of medications covered in this program
View List  
  • Avastin (bevacizumab)
  • Eylea (aflibercept)
  • Iluvien (fluocinolone acetonide)
  • Lucentis (ranibizumab)
  • Macugen (pegaptanib sodium)
  • Ozurdex (dexamethasone)
  • Retisert (fluocinolone acetonide)
  • Triesence (triamcinolone acetonide/pf)

Diagnosis Codes:

ICD-10: H34.8110, H34.8111, H34.8112, H34.8120, H34.8121, H34.8122, H34.8130, H34.8131, H34.8132, H34.8190, H34.8191, H34.8192, H34.831, H34.8310, H34.8311, H34.8312, H34.8320, H34.8321, H34.8322, H34.8330, H34.8331, H34.8332, H34.8390, H34.8391, H34.8392, H34.9

 

About the Disease:

Retinal vein occlusion (RVO) is a retinal disorder that occurs when small veins that carry blood away from the retina are blocked. RVO is a chronic disease that affects the nervous system.

 

Source: National Institutes of Health